ReP USP - Resultado da busca

Artigo de periodico
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 (2024)
Santos, Yasmin Silva ; Gamon, Thaís Helena Martins ; Azevedo, Marcela Santiago Pacheco de ; Bielavsky, Mônica ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Souza, Edmarcia Elisa de ; Luvizotto, Maria Cecília Rui ; Ackerman, Hans Christian; Carvalho, Leonardo José Moura; Epiphanio, Sabrina ; Wrenger, Carsten ; Durigon, Edison Luiz ; Marinho, Claudio Romero Farias
Source: Frontiers in Pharmacology. Unidades: FCF, ICB, BIOTECNOLOGIA
Subjects: PARASITOLOGIA, MICROBIOLOGIA, COVID-19, INIBIDORES DE ENZIMAS, DOENÇAS RESPIRATÓRIAS, ANGIOTENSINA II, SISTEMA RENINA-ANGIOTENSINA, ANTIVIRAIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin Silva et al. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, v. 15, 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1414406. Acesso em: 04 set. 2024.
APA
Santos, Y. S., Gamon, T. H. M., Azevedo, M. S. P. de, Bielavsky, M., Darido, M. L. G., Oliveira, D. B. L. de, et al. (2024). Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, 15. doi:10.3389/fphar.2024.1414406
NLM
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJM, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Vancouver
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJM, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Artigo de periodico
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
Silva, Mariângela de Oliveira ; Castro-Amarante, Maria Fernanda ; Carvalho, Alexia Adrianne Venceslau Brito ; Almeida, Bianca da Silva; Daher, Isabela Pazotti ; Souza-Silva, Guilherme Antonio de ; Yamamoto, Marcio Massao ; Koike, Gabriela ; Souza, Edmarcia Elisa de ; Wrenger, Carsten ; Ferreira, Luis Carlos de Souza ; Boscardin, Silvia Beatriz
Source: Vaccines. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MICROBIOLOGIA, PROTEÍNAS RECOMBINANTES, PROTEÍNAS SANGUÍNEAS, ANTICORPOS, IMUNOGENICIDADE DA VACINA, IMUNOGENÉTICA, IMUNOGLOBULINAS, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 04 set. 2024.
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/vaccines12040356
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/vaccines12040356
Artigo de periodico
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape (2023)
Oliveira, Jamille Ramos ; Ruiz, Cesar Manuel Remuzgo ; Machado, Rafael Rahal Guaragna ; Urbanski, Alysson Henrique ; Magawa, Jhosiene Yukari; Daher, Isabela Pazotti; Urbanski, Alysson Henrique ; Schmitz, Gabriela Justamante Händel ; Arcuri, Helen Andrade; Ferreira, Marcelo Alves ; Sasahara, Greyce Luri ; Medeiros, Giuliana Xavier de ; Silva Júnior, Roberto Carlos Vieira da ; Rosa, Daniela Santoro ; Nakaya, Helder Takashi Imoto ; Gadermaier, Gabriele; Coelho, Verônica ; Santos, Keity Souza ; Durigon, Edison Luiz ; Boscardin, Silvia Beatriz ; Schechtman, Deborah ; Cunha Neto, Edecio; Kalil Filho, Jorge Elias ; Coelho, Veronica Porto Carreiro de Vasconcellos
Source: Frontiers in Immunology. Unidades: ICB, IQ, FM, FCF
Subjects: MICROBIOLOGIA, PARASITOLOGIA, ANTICORPOS, COVID-19, VACINAS VIRAIS, EPITOPOS, IMUNOGLOBULINAS, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Jamille Ramos et al. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape. Frontiers in Immunology, v. 13, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1010105. Acesso em: 04 set. 2024.
APA
Oliveira, J. R., Ruiz, C. M. R., Machado, R. R. G., Urbanski, A. H., Magawa, J. Y., Daher, I. P., et al. (2023). Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.1010105
NLM
Oliveira JR, Ruiz CMR, Machado RRG, Urbanski AH, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, Medeiros GX de, Silva Júnior RCV da, Rosa DS, Nakaya HTI, Gadermaier G, Coelho V, Santos KS, Durigon EL, Boscardin SB, Schechtman D, Cunha Neto E, Kalil Filho JE, Coelho VPC de V. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape [Internet]. Frontiers in Immunology. 2023 ; 13 1-15.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.1010105
Vancouver
Oliveira JR, Ruiz CMR, Machado RRG, Urbanski AH, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, Medeiros GX de, Silva Júnior RCV da, Rosa DS, Nakaya HTI, Gadermaier G, Coelho V, Santos KS, Durigon EL, Boscardin SB, Schechtman D, Cunha Neto E, Kalil Filho JE, Coelho VPC de V. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape [Internet]. Frontiers in Immunology. 2023 ; 13 1-15.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.1010105
Artigo de periodico
The respiratory syncytial virus M2-2 protein is targeted for proteasome degradation and inhibits translation and stress granules assembly (2023)
Scudero, Orlando Bonito ; Santiago, Veronica Feijoli ; Palmisano, Giuseppe ; Simabuco, Fernando Moreira ; Ventura, Armando Morais
Source: PLOS ONE. Unidade: ICB
Subjects: MICROBIOLOGIA, PARASITOLOGIA, DOENÇAS RESPIRATÓRIAS, PROTEÍNAS, REPLICAÇÃO VIRAL, GENOMAS, REAÇÃO EM CADEIA POR POLIMERASE, MICRORNAS, CITOPLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCUDERO, Orlando Bonito et al. The respiratory syncytial virus M2-2 protein is targeted for proteasome degradation and inhibits translation and stress granules assembly. PLOS ONE, v. 18, n. 7, p. 26 , 2023Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0289100. Acesso em: 04 set. 2024.
APA
Scudero, O. B., Santiago, V. F., Palmisano, G., Simabuco, F. M., & Ventura, A. M. (2023). The respiratory syncytial virus M2-2 protein is targeted for proteasome degradation and inhibits translation and stress granules assembly. PLOS ONE, 18( 7), 26 . doi:10.1371/journal.pone.0289100
NLM
Scudero OB, Santiago VF, Palmisano G, Simabuco FM, Ventura AM. The respiratory syncytial virus M2-2 protein is targeted for proteasome degradation and inhibits translation and stress granules assembly [Internet]. PLOS ONE. 2023 ; 18( 7): 26 .[citado 2024 set. 04 ] Available from: https://doi.org/10.1371/journal.pone.0289100
Vancouver
Scudero OB, Santiago VF, Palmisano G, Simabuco FM, Ventura AM. The respiratory syncytial virus M2-2 protein is targeted for proteasome degradation and inhibits translation and stress granules assembly [Internet]. PLOS ONE. 2023 ; 18( 7): 26 .[citado 2024 set. 04 ] Available from: https://doi.org/10.1371/journal.pone.0289100
Artigo de periodico
Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice (2023)
Santos, Yasmin da Silva ; Oliveira, Danielle Bruna Leal de ; Palmisano, Giuseppe ; Wrenger, Carsten ; Covas, Dimas Tadeu ; Curi, Rui ; Marinho, Claudio Romero Farias ; Durigon, Edison Luiz ; Epiphanio, Sabrina
Source: Viruses. Unidades: ICB, FMRP, FCF
Subjects: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, VARIAÇÃO GENÉTICA, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, VIRULÊNCIA, CORONAVIRUS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin da Silva et al. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice. Viruses, v. 15, n. 4, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15040999. Acesso em: 04 set. 2024.
APA
Santos, Y. da S., Oliveira, D. B. L. de, Palmisano, G., Wrenger, C., Covas, D. T., Curi, R., et al. (2023). Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice. Viruses, 15( 4), 1-16. doi:10.3390/v15040999
NLM
Santos Y da S, Oliveira DBL de, Palmisano G, Wrenger C, Covas DT, Curi R, Marinho CRF, Durigon EL, Epiphanio S. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice [Internet]. Viruses. 2023 ; 15( 4): 1-16.[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/v15040999
Vancouver
Santos Y da S, Oliveira DBL de, Palmisano G, Wrenger C, Covas DT, Curi R, Marinho CRF, Durigon EL, Epiphanio S. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice [Internet]. Viruses. 2023 ; 15( 4): 1-16.[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/v15040999
Artigo de periodico
Protein Arginylation is regulated during SARS-CoV-2 infection (2023)
Silva, Janaina Macedo da ; Fernandes, Livia Rosa ; Gomes, Vinicius de Morais ; Santiago, Veronica Feijoli ; Santos, Deivid Martins ; Molnar Catarina Maria Stanischesk ; Barboza, Bruno Rafael ; Souza, Edmarcia Elisa de ; Marques, Rodolfo Ferreira ; Boscardin, Silvia Beatriz ; Durigon, Edison Luiz ; Marinho, Claudio Romero Farias ; Wrenger, Carsten ; Marie, Suely Kazue Nagahashi ; Palmisano, Giuseppe
Source: Viruses. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MICROBIOLOGIA, ENZIMAS, METABOLISMO DE PROTEÍNA, COVID-19, PROTEÍNAS, LISOSSOMOS, MACRÓFAGOS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Janaina Macedo da et al. Protein Arginylation is regulated during SARS-CoV-2 infection. Viruses, v. 15, n. 2, p. 1-25, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15020290. Acesso em: 04 set. 2024.
APA
Silva, J. M. da, Fernandes, L. R., Gomes, V. de M., Santiago, V. F., Santos, D. M., Molnar Catarina Maria Stanischesk,, et al. (2023). Protein Arginylation is regulated during SARS-CoV-2 infection. Viruses, 15( 2), 1-25. doi:10.3390/v15020290
NLM
Silva JM da, Fernandes LR, Gomes V de M, Santiago VF, Santos DM, Molnar Catarina Maria Stanischesk, Barboza BR, Souza EE de, Marques RF, Boscardin SB, Durigon EL, Marinho CRF, Wrenger C, Marie SKN, Palmisano G. Protein Arginylation is regulated during SARS-CoV-2 infection [Internet]. Viruses. 2023 ; 15( 2): 1-25.[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/v15020290
Vancouver
Silva JM da, Fernandes LR, Gomes V de M, Santiago VF, Santos DM, Molnar Catarina Maria Stanischesk, Barboza BR, Souza EE de, Marques RF, Boscardin SB, Durigon EL, Marinho CRF, Wrenger C, Marie SKN, Palmisano G. Protein Arginylation is regulated during SARS-CoV-2 infection [Internet]. Viruses. 2023 ; 15( 2): 1-25.[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/v15020290
Artigo de periodico
Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis (2023)
Santos, Suelen S. ; Rampazo, Eline; Nosanchuk, Joshua D. ; Boscardin, Silvia B. ; Almeida, Sandro Rogério de ; Taborda, Carlos Pelleschi
Source: Journal of Fungi. Unidades: ICB, FCF
Subjects: MICROBIOLOGIA, PARASITOLOGIA, PARACOCCIDIOIDOMICOSE, PARACOCCIDIOIDES BRASILIENSIS, CÉLULAS DENDRÍTICAS, PEPTÍDEOS, ANTICORPOS MONOCLONAIS, VACINAS, LINFÓCITOS T, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Suelen S. et al. Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis. Journal of Fungi, v. 9, n. 5, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/jof9050548. Acesso em: 04 set. 2024.
APA
Santos, S. S., Rampazo, E., Nosanchuk, J. D., Boscardin, S. B., Almeida, S. R. de, & Taborda, C. P. (2023). Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis. Journal of Fungi, 9( 5), 1-12. doi:10.3390/jof9050548
NLM
Santos SS, Rampazo E, Nosanchuk JD, Boscardin SB, Almeida SR de, Taborda CP. Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis [Internet]. Journal of Fungi. 2023 ; 9( 5): 1-12.[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/jof9050548
Vancouver
Santos SS, Rampazo E, Nosanchuk JD, Boscardin SB, Almeida SR de, Taborda CP. Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis [Internet]. Journal of Fungi. 2023 ; 9( 5): 1-12.[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/jof9050548
Artigo de periodico
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections (2023)
Reinke, Patrick Y. A ; Souza, Edmarcia Elisa de ; Günther, Sebastian ; Falke, Sven ; Lieske, Julia ; Ewert, Wiebke ; Loboda, Jure ; Herrmann, Alexander ; Mashhour, Aida Rahmani ; Karničar, Katarina ; Usenik, Aleksandra ; Lindič, Nataša ; Sekirnik, Andreja; Botosso, Viviane Fongaro ; Santelli, Glaucia Maria Machado ; Kapronezai, Josana ; Araujo, Marcelo Valdemir de ; Pereira, Taiana Tainá Silva ; Souza Filho, Antonio Francisco de ; Tavares, Mariana Silva; Flórez-Álvarez, Lizdany ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Giaretta, Paula Roberta ; Heinemann, Marcos Bryan ; Hauser, Maurice; Seychell, Brandon ; Böhler, Hendrik; Rut, Wioletta ; Drag, Marcin ; Beck, Tobias ; Cox, Russell ; Chapman, Henry N. ; Betzel, Christian ; Brehm, Wolfgang ; Hinrichs, Winfried ; Ebert, Gregor ; Latham, Sharissa L. ; Guimarães, Ana Marcia de Sá ; Turk, Dusan ; Wrenger, Carsten ; Meents, Alke
Source: Communications Biology. Unidades: ICB, FMVZ
Subjects: COVID-19, INIBIDORES DE ENZIMAS, ENZIMAS PROTEOLÍTICAS, ANTIVIRAIS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REINKE, Patrick Y. A et al. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections. Communications Biology, v. 6, p. 1-13, 2023Tradução . . Disponível em: https://doi.org/10.1038/s42003-023-05317-9. Acesso em: 04 set. 2024.
APA
Reinke, P. Y. A., Souza, E. E. de, Günther, S., Falke, S., Lieske, J., Ewert, W., et al. (2023). Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections. Communications Biology, 6, 1-13. doi:10.1038/s42003-023-05317-9
NLM
Reinke PYA, Souza EE de, Günther S, Falke S, Lieske J, Ewert W, Loboda J, Herrmann A, Mashhour AR, Karničar K, Usenik A, Lindič N, Sekirnik A, Botosso VF, Santelli GMM, Kapronezai J, Araujo MV de, Pereira TTS, Souza Filho AF de, Tavares MS, Flórez-Álvarez L, Oliveira DBL de, Durigon EL, Giaretta PR, Heinemann MB, Hauser M, Seychell B, Böhler H, Rut W, Drag M, Beck T, Cox R, Chapman HN, Betzel C, Brehm W, Hinrichs W, Ebert G, Latham SL, Guimarães AM de S, Turk D, Wrenger C, Meents A. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections [Internet]. Communications Biology. 2023 ; 6 1-13.[citado 2024 set. 04 ] Available from: https://doi.org/10.1038/s42003-023-05317-9
Vancouver
Reinke PYA, Souza EE de, Günther S, Falke S, Lieske J, Ewert W, Loboda J, Herrmann A, Mashhour AR, Karničar K, Usenik A, Lindič N, Sekirnik A, Botosso VF, Santelli GMM, Kapronezai J, Araujo MV de, Pereira TTS, Souza Filho AF de, Tavares MS, Flórez-Álvarez L, Oliveira DBL de, Durigon EL, Giaretta PR, Heinemann MB, Hauser M, Seychell B, Böhler H, Rut W, Drag M, Beck T, Cox R, Chapman HN, Betzel C, Brehm W, Hinrichs W, Ebert G, Latham SL, Guimarães AM de S, Turk D, Wrenger C, Meents A. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections [Internet]. Communications Biology. 2023 ; 6 1-13.[citado 2024 set. 04 ] Available from: https://doi.org/10.1038/s42003-023-05317-9
Artigo de periodico
Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes (2023)
Fotoran, Wesley L. ; Silva, Jamile Ramos da ; Glitz, Christiane ; Ferreira, Luís Carlos de Souza ; Wunderlich, Gerhard
Source: Pharmaceutics. Unidade: ICB
Subjects: MICROBILOGIA, PARASITOLOGIA, REPLICAÇÃO DO DNA, REPLICAÇÃO VIRAL, VACINAS VIRAIS, LIPOSSOMOS, ÁCIDOS NUCLEICOS, RNA MENSAGEIRO, COVID-19, NUCLEOSÍDEOS, MICRORNAS, MALÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOTORAN, Wesley L. et al. Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes. Pharmaceutics, v. 15, n. 4, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15041223. Acesso em: 04 set. 2024.
APA
Fotoran, W. L., Silva, J. R. da, Glitz, C., Ferreira, L. C. de S., & Wunderlich, G. (2023). Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes. Pharmaceutics, 15( 4), 1-17. doi:10.3390/pharmaceutics15041223
NLM
Fotoran WL, Silva JR da, Glitz C, Ferreira LC de S, Wunderlich G. Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-17.[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/pharmaceutics15041223
Vancouver
Fotoran WL, Silva JR da, Glitz C, Ferreira LC de S, Wunderlich G. Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-17.[citado 2024 set. 04 ] Available from: https://doi.org/10.3390/pharmaceutics15041223
Trabalho de evento-resumo
Resource sharing by outer membrane vesicles from a citrus pathogen (2023)
Araujo, Gabriel Guarany de ; Conforte, Matheus Matildes; Purificação, Aline Dias da ; Todeschini, Íris ; Cornejo, Edgar Enrique Llontop ; Pascale, Claudia Blanes Angeli ; Inague, Alex ; Yoshinaga, Marcos Yukio ; Souza, Robson Francisco de ; Papai, Rodrigo ; Luz, Maciel Santos ; Miyamoto, Sayuri ; Palmisano, Giuseppe ; Farah, Chuck Shaker ; Carvalho, Cristiane Rodrigues Guzzo
Source: Anais. Conference titles: Congresso Brasileiro de Microbiologia/CBM. Unidades: ICB, IQ, FMRP
Subjects: XANTHOMONAS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Gabriel Guarany de et al. Resource sharing by outer membrane vesicles from a citrus pathogen. 2023, Anais.. São Paulo: Sociedade Brasileira de Microbiologia/SBM, 2023. Disponível em: https://sbmicrobiologia.org.br/32cbm-anais/resumo.htm. Acesso em: 04 set. 2024.
APA
Araujo, G. G. de, Conforte, M. M., Purificação, A. D. da, Todeschini, Í., Cornejo, E. E. L., Pascale, C. B. A., et al. (2023). Resource sharing by outer membrane vesicles from a citrus pathogen. In Anais. São Paulo: Sociedade Brasileira de Microbiologia/SBM. Recuperado de https://sbmicrobiologia.org.br/32cbm-anais/resumo.htm
NLM
Araujo GG de, Conforte MM, Purificação AD da, Todeschini Í, Cornejo EEL, Pascale CBA, Inague A, Yoshinaga MY, Souza RF de, Papai R, Luz MS, Miyamoto S, Palmisano G, Farah CS, Carvalho CRG. Resource sharing by outer membrane vesicles from a citrus pathogen [Internet]. Anais. 2023 ;[citado 2024 set. 04 ] Available from: https://sbmicrobiologia.org.br/32cbm-anais/resumo.htm
Vancouver
Araujo GG de, Conforte MM, Purificação AD da, Todeschini Í, Cornejo EEL, Pascale CBA, Inague A, Yoshinaga MY, Souza RF de, Papai R, Luz MS, Miyamoto S, Palmisano G, Farah CS, Carvalho CRG. Resource sharing by outer membrane vesicles from a citrus pathogen [Internet]. Anais. 2023 ;[citado 2024 set. 04 ] Available from: https://sbmicrobiologia.org.br/32cbm-anais/resumo.htm
Artigo de periodico
Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells (2023)
Lunardelli, Victória Alves Santos ; Almeida, Bianca da Silva ; Apostolico, Juliana de Souza ; Rezende, Thais; Yamamoto, Marcio Massao ; Pereira, Samuel Santos ; Bueno, Maria Fernanda Campagnari ; Pereira, Lennon Ramos ; Karina Inacio Carvalho ; Slhessarenko, Renata Dezengrini ; Rosa, Daniela Santoro ; Ferreira, Luís Carlos de Souza ; Boscardin, Silvia Beatriz
Source: Frontiers in Immunology. Unidade: ICB
Subjects: MICROBIOLOGIA, PARASITOLOGIA, ZIKA VÍRUS, ZIKA VÍRUS, CAMUNDONGOS ENDOGÂMICOS C57BL, DROSOPHILA, VACINAS VIRAIS, INFECÇÕES POR VÍRUS DE RNA, PROTEÍNAS RECOMBINANTES, GLICOPROTEÍNAS, CÁPSULAS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUNARDELLI, Victória Alves Santos et al. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Frontiers in Immunology, v. 14, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2023.1071041. Acesso em: 04 set. 2024.
APA
Lunardelli, V. A. S., Almeida, B. da S., Apostolico, J. de S., Rezende, T., Yamamoto, M. M., Pereira, S. S., et al. (2023). Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Frontiers in Immunology, 14, 1-14. doi:10.3389/fimmu.2023.1071041
NLM
Lunardelli VAS, Almeida B da S, Apostolico J de S, Rezende T, Yamamoto MM, Pereira SS, Bueno MFC, Pereira LR, Karina Inacio Carvalho, Slhessarenko RD, Rosa DS, Ferreira LC de S, Boscardin SB. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells [Internet]. Frontiers in Immunology. 2023 ; 14 1-14.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fimmu.2023.1071041
Vancouver
Lunardelli VAS, Almeida B da S, Apostolico J de S, Rezende T, Yamamoto MM, Pereira SS, Bueno MFC, Pereira LR, Karina Inacio Carvalho, Slhessarenko RD, Rosa DS, Ferreira LC de S, Boscardin SB. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells [Internet]. Frontiers in Immunology. 2023 ; 14 1-14.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fimmu.2023.1071041
Trabalho de evento-resumo
The continuous use of lisinopril in humanized transgenic mice infected with SARS-COV-2 (2023)
Santos, Yasmin da Silva ; Gamon, Thaís Helena Martins ; Darido, M. L. G; Bielavsky, M; Marinho, Claudio Romero Farias ; Oliveira, D. B. L; Durigon, Edison Luiz ; Carvalho, L. J. M; Epiphanio, Sabrina
Source: Anais. Conference titles: Congresso Brasileiro de Virologia. Unidades: ICB, FCF
Subjects: VIRULÊNCIA, HIPERTENSÃO, MEDICAMENTO, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin da Silva et al. The continuous use of lisinopril in humanized transgenic mice infected with SARS-COV-2. 2023, Anais.. Belo Horizonte: Sociedade Brasileira de Virologia (SBV), 2023. Disponível em: https://sbv.org.br/files/anais/Anais_CBV2023.pdf. Acesso em: 04 set. 2024.
APA
Santos, Y. da S., Gamon, T. H. M., Darido, M. L. G., Bielavsky, M., Marinho, C. R. F., Oliveira, D. B. L., et al. (2023). The continuous use of lisinopril in humanized transgenic mice infected with SARS-COV-2. In Anais. Belo Horizonte: Sociedade Brasileira de Virologia (SBV). Recuperado de https://sbv.org.br/files/anais/Anais_CBV2023.pdf
NLM
Santos Y da S, Gamon THM, Darido MLG, Bielavsky M, Marinho CRF, Oliveira DBL, Durigon EL, Carvalho LJM, Epiphanio S. The continuous use of lisinopril in humanized transgenic mice infected with SARS-COV-2 [Internet]. Anais. 2023 ;[citado 2024 set. 04 ] Available from: https://sbv.org.br/files/anais/Anais_CBV2023.pdf
Vancouver
Santos Y da S, Gamon THM, Darido MLG, Bielavsky M, Marinho CRF, Oliveira DBL, Durigon EL, Carvalho LJM, Epiphanio S. The continuous use of lisinopril in humanized transgenic mice infected with SARS-COV-2 [Internet]. Anais. 2023 ;[citado 2024 set. 04 ] Available from: https://sbv.org.br/files/anais/Anais_CBV2023.pdf
Artigo de periodico
The impact of Zika virus exposure on the placental proteomic profile (2022)
Fernandes, Livia Rosa ; Bandeira, Carla Letícia dos ; Pour, Shahab Zaki ; Benedetti, Viviane de Fátima; Ferreira, Daniel; Lorenzon, Aline Rodrigues ; Moreli, Jusciele Brogin ; Marinho, Claudio Romero Farias ; Larsen, Martin R. ; Zanotto, Paolo Marinho de Andrade ; Palmisano, Giuseppe ; Bevilacqua, Estela Maris Andrade Forell
Source: Biochimica et Biophysica Acta. Molecular Basis of Disease. Unidade: ICB
Subjects: FINANCIAMENTO CNPQ, PARASITOLOGIA, MICROBIOLOGIA, BIOLOGIA CELULAR, PLACENTA, ZIKA VÍRUS, PROTEÔMICA, MEMBRANAS CELULARES, PROLIFERAÇÃO CELULAR, NEONATOLOGIA, APOPTOSE, SURTOS DE DOENÇAS, ANORMALIDADES CONGÊNITAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Livia Rosa et al. The impact of Zika virus exposure on the placental proteomic profile. Biochimica et Biophysica Acta. Molecular Basis of Disease, v. 1868, n. 1, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbadis.2021.166270. Acesso em: 04 set. 2024.
APA
Fernandes, L. R., Bandeira, C. L. dos, Pour, S. Z., Benedetti, V. de F., Ferreira, D., Lorenzon, A. R., et al. (2022). The impact of Zika virus exposure on the placental proteomic profile. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1868( 1), 1-12. doi:10.1016/j.bbadis.2021.166270
NLM
Fernandes LR, Bandeira CL dos, Pour SZ, Benedetti V de F, Ferreira D, Lorenzon AR, Moreli JB, Marinho CRF, Larsen MR, Zanotto PM de A, Palmisano G, Bevilacqua EMAF. The impact of Zika virus exposure on the placental proteomic profile [Internet]. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2022 ; 1868( 1): 1-12.[citado 2024 set. 04 ] Available from: https://doi.org/10.1016/j.bbadis.2021.166270
Vancouver
Fernandes LR, Bandeira CL dos, Pour SZ, Benedetti V de F, Ferreira D, Lorenzon AR, Moreli JB, Marinho CRF, Larsen MR, Zanotto PM de A, Palmisano G, Bevilacqua EMAF. The impact of Zika virus exposure on the placental proteomic profile [Internet]. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2022 ; 1868( 1): 1-12.[citado 2024 set. 04 ] Available from: https://doi.org/10.1016/j.bbadis.2021.166270
Artigo de periodico
Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation (2022)
Jesus, Monica Josiane Rodrigues de ; Favaro, Marianna Teixeira de Pinho ; Carvalho, Aléxia Adrianne Venceslau Brito ; Amarante, Maria Fernanda de Castro ; Almeida, Bianca da Silva ; Silva, Mariângela de Oliveira ; Santos, Robert Andreata ; Barbosa, Cecilia Gomes; Brito, Samantha Carvalho Maia; Freitas Junior, Lucio Holanda Gondim de ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Source: Nanomedicine: Nanotechnology, Biology and Medicine. Unidades: BIOTECNOLOGIA, ICB
Subjects: PARASITOLOGIA, MICROBIOLOGIA, VACINAS VIRAIS, IMUNOGLOBULINAS, CORONAVIRUS, COVID-19, LIPOPROTEÍNAS, NANOPARTÍCULAS, CAMUNDONGOS, IMUNOGENICIDADE DA VACINA, DOENÇAS RESPIRATÓRIAS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Monica Josiane Rodrigues de et al. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, v. 45, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2022.102595. Acesso em: 04 set. 2024.
APA
Jesus, M. J. R. de, Favaro, M. T. de P., Carvalho, A. A. V. B., Amarante, M. F. de C., Almeida, B. da S., Silva, M. de O., et al. (2022). Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, 45, 1-11. doi:10.1016/j.nano.2022.102595
NLM
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 set. 04 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Vancouver
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 set. 04 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Artigo de periodico
Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil (2022)
Santos, Robert Andreata ; Machado, Rafael Rahal Guaragna ; Alves, Rúbens Prince dos Santos ; Sales, Natiely Silva ; Soares, Camila Pereira ; Rodrigues, Karine Bitencourt ; Andrade, Juliana Bannwart ; Fock, Ricardo Ambrósio ; Margarido, Paulo Francisco Ramos ; Carvalho, Cristiane Rodrigues Guzzo ; Boscardin, Silvia Beatriz ; Durigon, Edison Luiz ; Ferreira, Luís Carlos de Souza
Source: Frontiers in Cellular and Infection Microbiology. Unidades: HU, ICB, FCF, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, TESTES SOROLÓGICOS, TRIAGEM, SERVIÇOS DE SAÚDE, ESTUDOS RETROSPECTIVOS, ANTICORPOS, ELISA, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Robert Andreata et al. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, v. 12, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.787411. Acesso em: 04 set. 2024.
APA
Santos, R. A., Machado, R. R. G., Alves, R. P. dos S., Sales, N. S., Soares, C. P., Rodrigues, K. B., et al. (2022). Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, 12, 1-8. doi:10.3389/fcimb.2022.787411
NLM
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Vancouver
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Artigo de periodico
Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system (2022)
Miranda, Renata Rank ; Ferreira, Natália Noronha ; Souza, Edmarcia Elisa de ; Lins, Paula Maria Pincela ; Ferreira, Leonardo Miziara Barboza; Kruger, Arne ; Cardoso, Valéria Maria de Oliveira; Durigon, Edison Luiz ; Wrenger, Carsten ; Zucolotto, Valtencir
Source: ACS Applied Bio Materials. Unidades: ICB, IFSC
Subjects: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, PLANEJAMENTO DE FÁRMACOS, NANOPARTÍCULAS, NANOTECNOLOGIA, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Renata Rank et al. Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system. ACS Applied Bio Materials, v. 5, n. 7, p. 3371-3383, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsabm.2c00349. Acesso em: 04 set. 2024.
APA
Miranda, R. R., Ferreira, N. N., Souza, E. E. de, Lins, P. M. P., Ferreira, L. M. B., Kruger, A., et al. (2022). Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system. ACS Applied Bio Materials, 5( 7), 3371-3383. doi:10.1021/acsabm.2c00349
NLM
Miranda RR, Ferreira NN, Souza EE de, Lins PMP, Ferreira LMB, Kruger A, Cardoso VM de O, Durigon EL, Wrenger C, Zucolotto V. Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system [Internet]. ACS Applied Bio Materials. 2022 ; 5( 7): 3371-3383.[citado 2024 set. 04 ] Available from: https://doi.org/10.1021/acsabm.2c00349
Vancouver
Miranda RR, Ferreira NN, Souza EE de, Lins PMP, Ferreira LMB, Kruger A, Cardoso VM de O, Durigon EL, Wrenger C, Zucolotto V. Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system [Internet]. ACS Applied Bio Materials. 2022 ; 5( 7): 3371-3383.[citado 2024 set. 04 ] Available from: https://doi.org/10.1021/acsabm.2c00349
Artigo de periodico
Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential (2022)
Flórez-Álvarez, Lizdany ; Souza, Edmarcia Elisa de ; Botosso, Viviane Fongaro ; Oliveira, Danielle Bruna Leal de ; Ho, Paulo Lee ; Taborda, Carlos Pelleschi ; Palmisano, Giuseppe ; Capurro, Margareth de Lara ; Pinho, Joao Renato Rebello ; Ferreira, Helena Lage ; Minoprio, Paola Marcella Camargo ; Arruda, Eurico; Ferreira, Luís Carlos de Souza ; Wrenger, Carsten ; Durigon, Edison Luiz
Source: Frontiers in Microbiology. Unidades: ICB, FM, FZEA, FMRP
Subjects: VIROLOGIA, DOENÇAS INFECCIOSAS, FEBRE HEMORRÁGICA COM SÍNDROME RENAL, INFLUENZA, PARASITOLOGIA, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FLÓREZ-ÁLVAREZ, Lizdany et al. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential. Frontiers in Microbiology, v. 13, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3389/fmicb.2022.1040093. Acesso em: 04 set. 2024.
APA
Flórez-Álvarez, L., Souza, E. E. de, Botosso, V. F., Oliveira, D. B. L. de, Ho, P. L., Taborda, C. P., et al. (2022). Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential. Frontiers in Microbiology, 13, 1-16. doi:10.3389/fmicb.2022.1040093
NLM
Flórez-Álvarez L, Souza EE de, Botosso VF, Oliveira DBL de, Ho PL, Taborda CP, Palmisano G, Capurro M de L, Pinho JRR, Ferreira HL, Minoprio PMC, Arruda E, Ferreira LC de S, Wrenger C, Durigon EL. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential [Internet]. Frontiers in Microbiology. 2022 ; 13 1-16.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fmicb.2022.1040093
Vancouver
Flórez-Álvarez L, Souza EE de, Botosso VF, Oliveira DBL de, Ho PL, Taborda CP, Palmisano G, Capurro M de L, Pinho JRR, Ferreira HL, Minoprio PMC, Arruda E, Ferreira LC de S, Wrenger C, Durigon EL. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential [Internet]. Frontiers in Microbiology. 2022 ; 13 1-16.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fmicb.2022.1040093
Trabalho de evento-resumo
Pulmonary evaluation of humanized transgenic mice (K18 hACE2) treated with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors (2022)
Santos, Yasmin Silva; Azevedo, Marcela Santiago Pacheco de ; Gamon, Thaís Helena Martins ; Marinho, Claudio Romero Farias ; Luvizotto, Maria Cecília Rui ; Durigon, Edison Luiz ; Carvalho, Leonardo José de Moura; Epiphanio, Sabrina
Source: Anais. Conference titles: Reunião Nacional de Pesquisa da Malária. Unidades: ICB, FCF, BIOTECNOLOGIA
Subjects: ANGIOTENSINAS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin Silva et al. Pulmonary evaluation of humanized transgenic mice (K18 hACE2) treated with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors. 2022, Anais.. Rio de Janeiro: Fiocruz, 2022. . Acesso em: 04 set. 2024.
APA
Santos, Y. S., Azevedo, M. S. P. de, Gamon, T. H. M., Marinho, C. R. F., Luvizotto, M. C. R., Durigon, E. L., et al. (2022). Pulmonary evaluation of humanized transgenic mice (K18 hACE2) treated with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors. In Anais. Rio de Janeiro: Fiocruz.
NLM
Santos YS, Azevedo MSP de, Gamon THM, Marinho CRF, Luvizotto MCR, Durigon EL, Carvalho LJ de M, Epiphanio S. Pulmonary evaluation of humanized transgenic mice (K18 hACE2) treated with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors. Anais. 2022 ;[citado 2024 set. 04 ]
Vancouver
Santos YS, Azevedo MSP de, Gamon THM, Marinho CRF, Luvizotto MCR, Durigon EL, Carvalho LJ de M, Epiphanio S. Pulmonary evaluation of humanized transgenic mice (K18 hACE2) treated with angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors. Anais. 2022 ;[citado 2024 set. 04 ]
Artigo de periodico
MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19 (2022)
Lazari, Lucas Cardoso ; Zerbinati, Rodrigo Melim ; Fernandes, Livia Rosa ; Santiago, Veronica Feijoli ; Rosa, Klaise F.; Pascale, Claudia Blanes Angeli ; Schwab, Gabriela Elsbeth Bitiati ; Palmieri, Michelle ; Sarmento, Dmitry José de Santana ; Marinho, Claudio Romero Farias ; Almeida, Janete Dias ; To, Kelvin ; Giannecchini, Simone; Wrenger, Carsten ; Sabino, Ester Cerdeira ; Martinho, Herculano ; Lindoso, José Angelo Lauletta ; Durigon, Edison Luiz ; Silva, Paulo Henrique Braz ; Palmisano, Giuseppe
Source: Journal of Oral Microbiology. Unidades: ICB, FM, FO
Subjects: PARASITOLOGIA, MICROBIOLOGIA, ESPECTROMETRIA DE MASSAS, SALIVA, BIOMARCADORES, PROTEÔMICA, COVID-19, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAZARI, Lucas Cardoso et al. MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19. Journal of Oral Microbiology, v. 14, n. 1, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1080/20002297.2022.2043651. Acesso em: 04 set. 2024.
APA
Lazari, L. C., Zerbinati, R. M., Fernandes, L. R., Santiago, V. F., Rosa, K. F., Pascale, C. B. A., et al. (2022). MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19. Journal of Oral Microbiology, 14( 1), 1-12. doi:10.1080/20002297.2022.2043651
NLM
Lazari LC, Zerbinati RM, Fernandes LR, Santiago VF, Rosa KF, Pascale CBA, Schwab GEB, Palmieri M, Sarmento DJ de S, Marinho CRF, Almeida JD, To K, Giannecchini S, Wrenger C, Sabino EC, Martinho H, Lindoso JAL, Durigon EL, Silva PHB, Palmisano G. MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19 [Internet]. Journal of Oral Microbiology. 2022 ; 14( 1): 1-12.[citado 2024 set. 04 ] Available from: https://doi.org/10.1080/20002297.2022.2043651
Vancouver
Lazari LC, Zerbinati RM, Fernandes LR, Santiago VF, Rosa KF, Pascale CBA, Schwab GEB, Palmieri M, Sarmento DJ de S, Marinho CRF, Almeida JD, To K, Giannecchini S, Wrenger C, Sabino EC, Martinho H, Lindoso JAL, Durigon EL, Silva PHB, Palmisano G. MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19 [Internet]. Journal of Oral Microbiology. 2022 ; 14( 1): 1-12.[citado 2024 set. 04 ] Available from: https://doi.org/10.1080/20002297.2022.2043651
Artigo de periodico
Reduced T Cell and antibody responses to inactivated Coronavirus vaccine among individuals above 55 Years old (2022)
Medeiros, Giuliana Xavier ; Sasahara, Greyce Luri ; Magawa, Jhosiene Yukari; Nunes, João Paulo Silva ; Bruno, Fernanda R.; Almeida, Rafael R.; Durigon, Danielle Bruna Leal de Oliveira ; Durigon, Edison Luiz ; Boscardin, Silvia Beatriz
Source: Frontiers in Immunology. Unidades: ICB, FM
Subjects: MICROBIOLOGIA, PARASITOLOGIA, CORONAVIRUS, VACINAÇÃO, LINFÓCITOS T, IMUNOGLOBULINAS, IMUNIZAÇÃO, INTERLEUCINA 2, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS, Giuliana Xavier et al. Reduced T Cell and antibody responses to inactivated Coronavirus vaccine among individuals above 55 Years old. Frontiers in Immunology, v. 13, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.812126. Acesso em: 04 set. 2024.
APA
Medeiros, G. X., Sasahara, G. L., Magawa, J. Y., Nunes, J. P. S., Bruno, F. R., Almeida, R. R., et al. (2022). Reduced T Cell and antibody responses to inactivated Coronavirus vaccine among individuals above 55 Years old. Frontiers in Immunology, 13, 1-10. doi:10.3389/fimmu.2022.812126
NLM
Medeiros GX, Sasahara GL, Magawa JY, Nunes JPS, Bruno FR, Almeida RR, Durigon DBL de O, Durigon EL, Boscardin SB. Reduced T Cell and antibody responses to inactivated Coronavirus vaccine among individuals above 55 Years old [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.812126
Vancouver
Medeiros GX, Sasahara GL, Magawa JY, Nunes JPS, Bruno FR, Almeida RR, Durigon DBL de O, Durigon EL, Boscardin SB. Reduced T Cell and antibody responses to inactivated Coronavirus vaccine among individuals above 55 Years old [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2024 set. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.812126

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration